Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project

生活方式因素与淋巴瘤:亚洲队列联盟联合项目

基本信息

  • 批准号:
    8513077
  • 负责人:
  • 金额:
    $ 10.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-15 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Non-Hodgkin lymphoma (NHL) is the most common hematopoietic cancer among adults in the United States. Studies conducted in Caucasian populations suggested that a higher body mass and smoking may increase risk while alcohol use may lower the risk. However, it is not known whether the same relationships exist in Asian populations for which incidence rates historically have been lower than Caucasians. Given the rising prevalence of obesity and cigarette smoking in many countries in Asia and immigrants in the US, there exists an urgent need to clarify the potential role of these modifiable factors in th NHL risk. The aims of this research are to investigate the associations between deaths from lymphoma and body mass, smoking, and alcohol use in Asian populations. To accomplish these aims, we will conduct a cohort analysis using data from the Asia Cohort Consortium; consisting of 17 cohorts with over 870,000 participants and 686 recorded NHL deaths. Data on body mass, tobacco smoking, and alcohol use have already been harmonized. Data on NHL deaths and person time for the current proposal have also been obtained from each cohort. We will examine the association between deaths from NHL and body mass, smoking, and alcohol consumption using Cox proportional hazard regression models. A two- stage method for analysis of pooled data will be used to compare the risk estimates from fixed- effects models with those from random-effects models to assess the effect of heterogeneity. Using existing data from the Asia Cohort Consortium, the proposed study is extremely cost-effective for clarifying the relationship between body mass, smoking, and alcohol use and risk of NHL and extending findings to the Asian populations, one of the fastest growing ethnic groups in the United States.
描述(由申请人提供):非霍奇金淋巴瘤(NHL)是美国成人中最常见的造血系统癌症。在高加索人群中进行的研究表明,较高的体重和吸烟可能会增加风险,而饮酒可能会降低风险。然而,目前尚不清楚亚洲人群是否存在相同的关系,因为亚洲人群的发病率历史上一直低于高加索人。鉴于亚洲许多国家和美国移民中肥胖和吸烟的患病率不断上升,迫切需要澄清这些可改变因素在NHL风险中的潜在作用。本研究的目的是调查亚洲人群中淋巴瘤死亡与体重、吸烟和饮酒之间的关系。为了实现这些目标,我们将使用来自亚洲队列联盟的数据进行队列分析;包括17个队列,超过870,000名参与者和686例记录的NHL死亡。关于体重、吸烟和饮酒的数据已经统一。还从每个队列中获得了当前提案的NHL死亡和人时间数据。我们将使用考克斯比例风险回归模型研究NHL死亡与体重、吸烟和饮酒之间的关系。将使用两阶段方法分析汇总数据,比较固定效应模型与随机效应模型的风险估计值,以评估异质性的影响。利用亚洲队列联盟的现有数据,拟议的研究对于澄清体重,吸烟和饮酒与NHL风险之间的关系以及将研究结果扩展到亚洲人群(美国增长最快的种族群体之一)具有极高的成本效益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN C-H CHIU其他文献

BRIAN C-H CHIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN C-H CHIU', 18)}}的其他基金

Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
阐明与多发性骨髓瘤风险差异相关的新型表观遗传修饰
  • 批准号:
    10912191
  • 财政年份:
    2023
  • 资助金额:
    $ 10.02万
  • 项目类别:
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma
整合基于液体活检的表观遗传学和成像方式来评估多发性骨髓瘤的疾病反应
  • 批准号:
    10651370
  • 财政年份:
    2023
  • 资助金额:
    $ 10.02万
  • 项目类别:
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research
用于临床癌症研究的基于高灵敏度线性扩增的 DNA 甲基化分析技术
  • 批准号:
    10640969
  • 财政年份:
    2022
  • 资助金额:
    $ 10.02万
  • 项目类别:
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research
用于临床癌症研究的基于高灵敏度线性扩增的 DNA 甲基化分析技术
  • 批准号:
    10413620
  • 财政年份:
    2022
  • 资助金额:
    $ 10.02万
  • 项目类别:
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma
多发性骨髓瘤循环游离 DNA 的表观基因组标记和治疗结果
  • 批准号:
    10204951
  • 财政年份:
    2018
  • 资助金额:
    $ 10.02万
  • 项目类别:
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma
多发性骨髓瘤循环游离 DNA 的表观基因组标记和治疗结果
  • 批准号:
    10430121
  • 财政年份:
    2018
  • 资助金额:
    $ 10.02万
  • 项目类别:
Using epigenomic subtyping to understand the racial differences in lymphoma
使用表观基因组亚型来了解淋巴瘤的种族差异
  • 批准号:
    9455051
  • 财政年份:
    2017
  • 资助金额:
    $ 10.02万
  • 项目类别:
Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project
生活方式因素与淋巴瘤:亚洲队列联盟联合项目
  • 批准号:
    8637023
  • 财政年份:
    2013
  • 资助金额:
    $ 10.02万
  • 项目类别:
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival
生活方式与肿瘤途径和微环境对淋巴瘤生存的影响
  • 批准号:
    7663557
  • 财政年份:
    2009
  • 资助金额:
    $ 10.02万
  • 项目类别:
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival
生活方式与肿瘤途径和微环境对淋巴瘤生存的影响
  • 批准号:
    8245331
  • 财政年份:
    2009
  • 资助金额:
    $ 10.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了